Events

ISCT is the global leader focused on pre-clinical and translational aspects of developing cell and gene-based therapeutics, thereby advancing scientific research into innovative treatments for patients. ISCT offers a unique collaborative environment that addresses three key areas of translation: Academia, Regulatory, and Commercialization. Through strong relationships with global regulatory agencies, academic institutions, and industry partners, ISCT drives the advancement of research into a standard of care

The conference theme, Collaborating to Improve Healthcare Decision Making for All: Expanding HEOR Horizons, underscores the pivotal role of health economics and outcomes research (HEOR) in transforming healthcare systems. By fostering cross-sector collaboration among researchers, clinicians, policymakers, and industry leaders, the theme highlights how HEOR can empower data-driven, patient-centered decision making that leads to more equitable, accessible, and effective healthcare solutions.

The Evidence 360: RWE, Pricing & Reimbursement Summit Europe focuses on the impact of Real World Evidence (RWE), pricing models, and reimbursement strategies in healthcare, addressing challenges like data analytics, regulatory issues, and personalized medicine in Europe.

With 36 Sponsors and Exhibitors taking part in 2024 and over 230 pre-registered delegates from across the MedTech, Life Sciences and NHS sector, the Expo also incorporated a conference stream over the day with a mix of topics suited for the audience.

Europe's Must-Attend Event for the Market Access Professionals in Pharma, Biotech and Lifescience. Pharma MARCON is the leading Market Access event for Pharma and Biotech in Europe bringing together 120+ senior MA and pricing professionals from across the pharma and biotech landscape for networking and exchange. Join us now and discuss the key industry topics and to create new partnerships

Join global healthcare leaders as they convene at ISPOR Europe 2025, the leading global conference in Europe for Health Economics and Outcomes Research (HEOR) for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

By bringing together people with rare diseased and patient advocates, policy makers, healthcare industry representatives, clinicians, regulators and Member State representatives EURORDIS harnesses the power of this extensive network to shape goal-driven rare disease policies of the future.